Pune, Maharastra -- (SBWire) -- 03/10/2016 --RnRMarketResearch.com adds Global Tissue Diagnostics Market 2016-2020 a new research reports in its store. The analysts forecast global tissue diagnostics market to grow at a CAGR of 11.59% during the period 2016-2020.

Complete report available @ http://www.rnrmarketresearch.com/global-tissue-diagnostics-market-2016-2020-market-report.html

Commenting on the report, an analyst said: "Ready-to-use reagents help minimize calculation, dilution, and pipetting errors, reduce the duration of the diagnostic procedure, and prevent contamination of samples. These factors have resulted in the demand for ready-to-use reagents among clinical laboratories and hospitals."

According to the report, hospital-based pathology laboratories widely use tissue diagnostics for disease diagnosis, while pharmaceutical companies use them for drug discovery. Advances in technology are leading academia and research institutes, reference pathology laboratories, and medical research centers worldwide to use tissue diagnostics for various medical purposes. The implementation of tissue diagnostics by these new consumers can become a turning point for the market in the coming years.

Purchase report directly @ http://www.rnrmarketresearch.com/contacts/purchase?rname=494006 Single user copy USD2500

Further, the report states that the insurance coverage and reimbursement policies for tissue diagnostics continue to concern policy makers and are leading individuals to opt for conventional therapies.

Top vendors are Abbott Diagnostics, Agilent Technologies (a parent company of Dako), Danaher (a parent company of Leica Biosystems) and Roche Diagnostics.
Other Prominent Vendors in the market are: 20/20 GeneSystems, Abcam, AdnaGen, Advanced Cell Diagnostics, Affymetrix, Agendia, AutoGenomics, AVIVA BioSciences, Biocare Medical, Biocartis, Cancer Genetics, ELITechGroup, Enzo Biochem, Epic Sciences, Fluidigm, HORIBA Medical, Janssen Diagnostics, Olympus Diagnostics Systems Group, Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US), Oxford Gene Technology, PANAGENE, Protea Biosciences Group and Sakura Finetek.

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the Key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

For more information Inquire @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=494006

Table of Content for Tissue Diagnostics Market 2016-2020:
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Global cancer statistics
PART 06: Reimbursement and coverage: An overview
Current scenario: Validating diagnostic tests
Reimbursement structure in US
Reimbursement structure in EU
Prevailing issues of reimbursement policies
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation by technology
Global tissue diagnostics market by advanced staining
Global tissue diagnostics market by digital pathology
Global tissue diagnostics market by preanalytical and routine staining
PART 09: Market segmentation by product
Global tissue diagnostics market segmentation by consumables
Global tissue diagnostics market segmentation by instruments
PART 10: Market segmentation by disease
Breast cancer
Lung cancer
Colorectal cancer
Lymphoma
Cervical cancer
Prostate cancer
Other diseases
PART 11: Market segmentation by end-user
Hospitals
CROs
Academia and research institutes
PART 12: Geographical segmentation
Tissue diagnostics market in Americas
Tissue diagnostics market in EMEA
Tissue diagnostics market in APAC
PART 13: Market drivers
Prevalence of chronic diseases
Implementation by new consumers
Use of biomarkers for disease diagnosis
Demand for personalized medicine
PART 14: Impact of drivers
PART 15: Market challenges
Insurance coverage and reimbursement issues
Limitations of closed systems
High initial investment and maintenance costs
PART 16: Impact of drivers and challenges
PART 17: Market trends
Ready-to-use reagents
Focus on system automation
Increase in M&A
PART 18: Vendor landscape
Competitive scenario
Market share analysis 2015
PART 19: Appendix
List of abbreviations
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Prevalent cancer types worldwide 2012
Exhibit 03: Countries with highest cancer rate 2012
Exhibit 04: Cancer statistics by gender 2012
Exhibit 05: Reimbursement perspectives of healthcare entities
Exhibit 06: Global tissue diagnostics market 2015-2020 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Global tissue diagnostics market segmentation by technology
Exhibit 09: Global tissue diagnostics market segmentation by technology 2015
Exhibit 10: Global tissue diagnostics market segmentation by technology 2020
And more.

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.